Moderna Inc (NASDAQ:MRNA) shares, rose in value, with the stock price down by -0.99% to the previous day’s close as strong demand from buyers drove the stock to $24.94.
Actively observing the price movement in the recent trading, the stock is buoying the session at $25.19, falling within a range of $24.68 and $25.28. The value of beta (5-year monthly) is 2.233. Referring to stock’s 52-week performance, its high was $170.47, and the low was $23.15. On the whole, MRNA has fluctuated by -25.15% over the past month.
With the market capitalization of Moderna Inc currently standing at about $9.62 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-13.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 2.16B, with a low estimate of 83M and a high estimate of 183M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 125.93M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MRNA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of MRNA currently trading nearly -10.97% and -20.17% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.21, while the 7-day volatility ratio is showing 6.47% which for the 30-day chart, stands at 7.26%. Furthermore, Moderna Inc (MRNA)’s beta value is 1.99, and its average true range (ATR) is 2.11.
A comparison of Moderna Inc (MRNA) with its peers suggests the former has fared considerably weaker in the market. MRNA showed an intraday change of -0.99% in today’s session so far, and over the past year, it shrunk by -75.97%%.
Data on historical trading for Moderna Inc (NASDAQ:MRNA) indicates that the trading volumes over the past 10 days have averaged 10.68 and over the past 3 months, they’ve averaged 11.37 million. According to company’s latest data on outstanding shares, there are 386.00 million shares outstanding.
Nearly 11.45% of Moderna Inc’s shares belong to company insiders and institutional investors own 71.06% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 49.8 million shares as on 2025-03-31, resulting in a short ratio of 5.11. According to the data, the short interest in Moderna Inc (MRNA) stood at 1789.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 45.06 million. The stock has fallen by -40.02% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRNA stock heading into the next quarter.
